The immunobiology of natural killer cells and bone marrow allograft rejection
Open Access
- 31 December 2003
- journal article
- review article
- Published by Elsevier BV in Transplantation and Cellular Therapy
- Vol. 9 (12), 727-741
- https://doi.org/10.1016/j.bbmt.2003.09.002
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (RO1CA93527-02)
- American Cancer Society (RSG-02-169-01)
This publication has 91 references indexed in Scilit:
- Increased bone marrow allograft rejection by depletion of NK cells expressing inhibitory Ly49 NK receptors for donor class I antigensBlood, 2002
- Activating Receptors and Coreceptors Involved in Human Natural Killer Cell-Mediated CytolysisAnnual Review of Immunology, 2001
- p46, a Novel Natural Killer Cell–specific Surface Molecule That Mediates Cell ActivationThe Journal of Experimental Medicine, 1997
- Host MHC class I gene control of NK‐cell specificity in the mouseImmunological Reviews, 1997
- Inhibitory MHC class I receptors on NK and T cells: a standard nomenclatureImmunology Today, 1996
- The Role of Ly49A and 5E6(Ly49C) Molecules in Hybrid Resistance Mediated by Murine Natural Killer Cells Against Normal T Cell BlastsImmunity, 1996
- Natural Killer Cells and Bone Marrow TransplantationJNCI Journal of the National Cancer Institute, 1993
- In search of the ‘missing self’: MHC molecules and NK cell recognitionImmunology Today, 1990
- Human Natural Killer Clones Enhance in Vitro Antibody Production by Tumour Necrosis Factor Alpha and Gamma InterferonScandinavian Journal of Immunology, 1990
- Natural killer (NK) cell-derived hematopoietic colony-inhibiting activity and NK cytotoxic factor. Relationship with tumor necrosis factor and synergism with immune interferon.The Journal of Experimental Medicine, 1985